Recent news on Sodium Iodide I-131

DRAXIS Health Reports Results for the First Quarter of 2007  -  May 9, 2007
Earthtimes.org...a result of increased sales to US based customers of cold kits and radioiodine products, specifically Sodium Iodide I-131 including diagnostic capsules.

DRAXIS Posts Record Earnings and Cash Flow for 2006  -  Feb 8, 2007
CNW Telbec (Communiqués de presse),The increase was primarily due to continued growth in radioiodine product sales, specifically Sodium Iodide I-131, including diagnostic capsules,

DRAXIS Health Third Quarter on Track for Record Year  Nov 2, 2006
...product line in late 2005), primarily as a result of increased sales of radioiodine products, specifically Sodium Iodide I-131, including diagnostic capsules ... -Earthtimes.org DRAXIS Second Quarter Shows a Return to Strong Performance  Aug 10, 2006
Radiopharmaceutical product sales grew 13% for the second quarter, driven primarily by increased sales of Sodium Iodide I-131 products in the United States. ... -MSN Money

Sodium Iodide I-131 Capsules Approved for Diagnostics  Jun 30, 2006
...has received approval from the United States Food and Drug Administration (FDA) for its supplemental new drug application for Sodium Iodide I-131 capsules for ... -Cancer Consultants



DRAXIS Health Reports Results for the First Quarter of 2006  May 11, 2006
Company received approval from the US Food and Drug Administration ("FDA") regarding its supplemental new drug application for Sodium Iodide I-131 Capsules USP ... - Yahoo! News





DRAXIS Health Reports Fourth Quarter and Year End 2005 Results  09 Feb 2006
The increases primarily result from higher sales of radioiodine products, specifically higher volumes of sodium iodide I-131, resulting from greater US market ... - Canada NewsWire

DRAXIS Receives FDA Approval for Diagnostic Iodine I-131 Capsules  Jan 13, 2006
DRAX) has received approval from the US Food and Drug Administration (FDA) regarding its supplemental new drug application for Sodium Iodide I-131 Capsules USP ... - PR Newswire

DRAXIS Receives FDA Approval for Diagnostic Iodine I-131 Capsules  Jan 13, 2006
...has received approval from the US Food and Drug Administration (FDA) regarding its supplemental new drug application for Sodium Iodide I-131 Capsules USP ... - PharmaLive.com

Draxis Health receives FDA approval for diagnostic iodine capsules  Jan 13, 2006
The drug developer said Friday the FDA approved the application for oral Sodium Iodide I-131 Capsules USP, used to perform the radioactive iodide uptake tests ... - Calgary Sun

Draxis gets FDA OK for iodide capsules  Jan 13, 2006
The approval allows Mississauga, Ontario-based Draxis to market sodium iodide I-131 capsules as a radioactive iodide uptake test to determine how much ... - BusinessWeek

Health Stocks in Motion  Jan 13, 2006
DRAX:Nasdaq - commentary - research - Cramer's Take) rose 2% after the company's new drug application for diagnostic sodium iodide I-131 capsules received Food ... - TheStreet.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional